Recurrent erythema nodosum leprosum associated with Mycobacterium indicus pranii vaccine in a case of leprosy: a rare paradox
- 15 February 2021
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (6) , E391-E393
Abstract
Erythema nodosum leprosum (ENL) is the commonest manifestation of type 2 lepra reaction (T2LR) due to immune complex mediated inflammation in patients of lepromatous (LL) and borderline lepromatous (BL) leprosy. Vaccines given as immunotherapy in leprosy may expedite early smear negativity and may hasten complete recovery. However, vaccination can also be associated with reactions. Majority of vaccine induced lepra reactions were reported about five decades back in the era of smallpox vaccination.Keywords
This publication has 5 references indexed in Scilit:
- Modulation of immune responses using adjuvants to facilitate therapeutic vaccinationImmunological Reviews, 2020
- Erythema Nodosum Leprosum Triggered by Antecedent Influenza Vaccine and Respiratory Tract Infection: A Case ReportJournal of Cutaneous Medicine and Surgery, 2018
- Development of a potent invigorator of immune responses endowed with both preventive and therapeutic propertiesBiologics: Targets and Therapy, 2017
- 10–12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapyVaccine, 2004
- Consequences of Smallpox Vaccination in Leprosy PatientsInfection and Immunity, 1973